Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043138 | 12504313 | 8 | F | 20160502 | 20160919 | 20160628 | 20160927 | EXP | US-PFIZER INC-2016314569 | PFIZER | 42.00 | YR | F | Y | 86.20000 | KG | 20160927 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125043138 | 12504313 | 1 | PS | EPINEPHRINE/LIDOCAINE HYDROCHLORIDE | EPINEPHRINELIDOCAINE HYDROCHLORIDE | 1 | UNK | U | 52460DK | 89645 | SOLUTION FOR INJECTION | ||||||||
| 125043138 | 12504313 | 2 | SS | LIDOCAINE HCL | LIDOCAINE HYDROCHLORIDE | 1 | Intracervical | 10 ML, UNK (1%) | Y | 18021 | 80408 | 10 | ML | SOLUTION FOR INJECTION | |||||
| 125043138 | 12504313 | 3 | SS | LIDOCAINE HCL | LIDOCAINE HYDROCHLORIDE | 1 | Y | 80408 | SOLUTION FOR INJECTION | ||||||||||
| 125043138 | 12504313 | 4 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | UNK, (5/325), (1 HR PRIOR) | 0 | |||||||||||
| 125043138 | 12504313 | 5 | C | TORADOL | KETOROLAC TROMETHAMINE | 1 | Intramuscular | 60 MG, UNK (15' PRIOR) | 57-132-DK | 0 | 80 | MG | |||||||
| 125043138 | 12504313 | 6 | C | VALIUM | DIAZEPAM | 1 | Oral | 10 MG, UNK, (1HR PRIOR) | 0 | 10 | MG | ||||||||
| 125043138 | 12504313 | 7 | C | VALIUM | DIAZEPAM | 1 | UNK | 0 | |||||||||||
| 125043138 | 12504313 | 8 | C | CYTOTEC | MISOPROSTOL | 1 | UNK, 1X/DAY (200/EVENING PRIOR) | 0 | QD | ||||||||||
| 125043138 | 12504313 | 9 | C | CYTOTEC | MISOPROSTOL | 1 | 200 UG, UNK, (LAST NIGHT) | 0 | 200 | UG | |||||||||
| 125043138 | 12504313 | 10 | C | IBUPROFEN. | IBUPROFEN | 1 | 600 MG, 1X/DAY (EVENING PRIOR) | 0 | 600 | MG | QD | ||||||||
| 125043138 | 12504313 | 11 | C | B+O | 2 | UNK, (15' PRIOR) | 0 | SUPPOSITORY | |||||||||||
| 125043138 | 12504313 | 12 | C | MOTRIN | IBUPROFEN | 1 | 800 MG, UNK, (LAST NIGHT) | 0 | 800 | MG | |||||||||
| 125043138 | 12504313 | 13 | C | PHENERGAN | PROMETHAZINE HYDROCHLORIDE | 1 | 25 MG, UNK, (1 HR AGO) | 0 | 25 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125043138 | 12504313 | 2 | Local anaesthesia |
| 125043138 | 12504313 | 3 | Anaesthesia procedure |
| 125043138 | 12504313 | 4 | Analgesic therapy |
| 125043138 | 12504313 | 5 | Analgesic therapy |
| 125043138 | 12504313 | 6 | Anxiolytic therapy |
| 125043138 | 12504313 | 8 | Cervix disorder |
| 125043138 | 12504313 | 10 | Analgesic therapy |
| 125043138 | 12504313 | 11 | Analgesic therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125043138 | 12504313 | OT |
| 125043138 | 12504313 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125043138 | 12504313 | Drug hypersensitivity | |
| 125043138 | 12504313 | Fatigue | |
| 125043138 | 12504313 | Generalised tonic-clonic seizure | |
| 125043138 | 12504313 | Loss of consciousness | |
| 125043138 | 12504313 | Postictal state | |
| 125043138 | 12504313 | Rales | |
| 125043138 | 12504313 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125043138 | 12504313 | 2 | 20160502 | 20160502 | 0 |